NASDAQ
Amicus Therapeutics, Inc. (FOLD) has a revenue compound annual growth rate of 19.44% over 5 years and 86.83% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.